User profiles for Diana M. Sobieraj
Diana M. SobierajAssociate Professor, University of Connecticut Verified email at uconn.edu Cited by 3741 |
Dosing frequency and medication adherence in chronic disease
CI Coleman, B Limone, DM Sobieraj, S Lee… - Journal of Managed …, 2012 - jmcp.org
BACKGROUND: Prior research has shown a decrease in medication adherence as dosing
frequency increases; however, meta-analyses have not been able to demonstrate a …
frequency increases; however, meta-analyses have not been able to demonstrate a …
Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a …
DM Sobieraj, ER Weeda, E Nguyen, CI Coleman… - Jama, 2018 - jamanetwork.com
Importance Combined use of inhaled corticosteroids and long-acting β-agonists (LABAs) as
the controller and the quick relief therapy termedsingle maintenance and reliever therapy(…
the controller and the quick relief therapy termedsingle maintenance and reliever therapy(…
<? covid19?> Myth Busters: dietary supplements and COVID-19
…, WL Baker, DM Sobieraj - Annals of …, 2020 - journals.sagepub.com
News and social media platforms have implicated dietary supplements in the treatment and
prevention of coronavirus disease 2019 (COVID-19). During this pandemic when information …
prevention of coronavirus disease 2019 (COVID-19). During this pandemic when information …
Effect of dosing frequency on chronic cardiovascular disease medication adherence
CI Coleman, MS Roberts, DM Sobieraj… - … medical research and …, 2012 - Taylor & Francis
Background: Many cardiovascular diseases (CVDs) require patients to take one or more
long term medications, often administered multiple times a day. We sought to determine the …
long term medications, often administered multiple times a day. We sought to determine the …
[HTML][HTML] Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis
Introduction When first line therapy with metformin is insufficient for patients with type 2 diabetes
(T2D), the optimal adjunctive therapy is unclear. We assessed the efficacy and safety of …
(T2D), the optimal adjunctive therapy is unclear. We assessed the efficacy and safety of …
Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose
Introduction While chloroquine, a derivative of quinine, has been used as an antimalarial for
70 years, hydroxychloroquine is now used to treat conditions such as rheumatoid arthritis …
70 years, hydroxychloroquine is now used to treat conditions such as rheumatoid arthritis …
The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis
R Talati, DM Sobieraj, SS Makanji, OJ Phung… - Journal of the American …, 2010 - Elsevier
BACKGROUND: Plant sterols and stanols are plant steroids with a similar chemical structure
and cellular function to human cholesterol, and are recommended as dietary modifiers of …
and cellular function to human cholesterol, and are recommended as dietary modifiers of …
Association of inhaled corticosteroids and long-acting muscarinic antagonists with asthma control in patients with uncontrolled, persistent asthma: a systematic review …
DM Sobieraj, WL Baker, E Nguyen, ER Weeda… - Jama, 2018 - jamanetwork.com
Importance Long-acting muscarinic antagonists (LAMAs) are a potential adjunct therapy to
inhaled corticosteroids in the management of persistent asthma. Objective To conduct a …
inhaled corticosteroids in the management of persistent asthma. Objective To conduct a …
Minimally important clinical difference of the Timed 25-Foot Walk Test: results from a randomized controlled trial in patients with multiple sclerosis
CI Coleman, DM Sobieraj… - Current medical research …, 2012 - Taylor & Francis
Background: Limited data define what constitutes a clinically significant change on the Timed
25-Foot Walk (T25FW) in multiple sclerosis (MS); however, most studies suggest a value of …
25-Foot Walk (T25FW) in multiple sclerosis (MS); however, most studies suggest a value of …
Adverse effects of pharmacologic treatments of major depression in older adults
DM Sobieraj, BK Martinez… - Journal of the …, 2019 - Wiley Online Library
OBJECTIVES To assess adverse effects of pharmacologic antidepressants for treatment of
major depressive disorder (MDD) in adults 65 years of age or older. DESIGN Systematic …
major depressive disorder (MDD) in adults 65 years of age or older. DESIGN Systematic …